In mouse models, miR - 29 not only
blocked pulmonary fibrosis, it reversed fibrosis after several days.
Not exact matches
«Inhibiting DGKi seems to reverse the effects of cystic
fibrosis, but not
block ENaC completely,» says Margarida Amaral from the University of Lisboa, «indeed, inhibiting DGKi reduces ENaC activity enough for cells to go back to normal, but not so much that they cause other problems, like
pulmonary oedema.»
Development of inhibitors of metabolic pathways to
block oncogenes or signalling molecules in malignant processes and specific inflammatory processes, such as
pulmonary artery hypertension or idiopathic
pulmonary fibrosis.